SPX3,585.62-54.85 -1.51%
DIA287.30-4.91 -1.68%
IXIC10,575.62-161.89 -1.51%

BRIEF-Medicinova: Received Notice Of Allowance For New Patent Covering Mn-001 And Mn-002 For Treatment Of Hypertriglyceridemia, Hypercholesterolemia, And Hyperlipoproteinemia In Canada

BRIEF-Medicinova: Received Notice Of Allowance For New Patent Covering Mn-001 And Mn-002 For Treatment Of Hypertriglyceridemia, Hypercholesterolemia, And Hyperlipoproteinemia In Canada

Reuters · 09/13/2022 19:11
BRIEF-Medicinova: Received Notice Of Allowance For New Patent Covering Mn-001 And Mn-002 For Treatment Of Hypertriglyceridemia, Hypercholesterolemia, And Hyperlipoproteinemia In Canada

-

  • MEDICINOVA: RECEIVED NOTICE OF ALLOWANCE FOR NEW PATENT COVERING MN-001 AND MN-002 FOR TREATMENT OF HYPERTRIGLYCERIDEMIA, HYPERCHOLESTEROLEMIA, AND HYPERLIPOPROTEINEMIA IN CANADA

Further company coverage: MNOV.O


(Reporting by Tokyo Newsroom)

((+81345201189;))